
Sign up to save your podcasts
Or
Cell therapies are at the cutting edge of personalized medicine but as demand for these therapies grows, how will the industry scale manufacturing to meet patient needs?
Fabian Gerlinghaus is co-founder and CEO of Cellares. He and his team have developed the Cell Shuttle, an advanced cell manufacturing technology that is already demonstrating the potential to 10x cell yields while halving costs for pharmaceuticals companies and innovators. Is this the future for smart cell manufacturing?
0:52 A starting point in aeronautical engineering
2:43 First steps into biotech
5:25 Co-founding Cellares
6:30 The problem that Cellares addresses
11:02 Best practice bio manufacturing
17:14 Differentiation in automation
18:15 What does success look like for Cellares
19:38 Smart factories
21:58 Inside the Cellares smart factory
26:34 Manufacturing CAR-T and stem cell therapies
27:54 Mass production vs personalized medicine
31:39 Global ambitions and regional regulators
35:07 Positioning Cellares in the market
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
3.3
33 ratings
Cell therapies are at the cutting edge of personalized medicine but as demand for these therapies grows, how will the industry scale manufacturing to meet patient needs?
Fabian Gerlinghaus is co-founder and CEO of Cellares. He and his team have developed the Cell Shuttle, an advanced cell manufacturing technology that is already demonstrating the potential to 10x cell yields while halving costs for pharmaceuticals companies and innovators. Is this the future for smart cell manufacturing?
0:52 A starting point in aeronautical engineering
2:43 First steps into biotech
5:25 Co-founding Cellares
6:30 The problem that Cellares addresses
11:02 Best practice bio manufacturing
17:14 Differentiation in automation
18:15 What does success look like for Cellares
19:38 Smart factories
21:58 Inside the Cellares smart factory
26:34 Manufacturing CAR-T and stem cell therapies
27:54 Mass production vs personalized medicine
31:39 Global ambitions and regional regulators
35:07 Positioning Cellares in the market
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
3,446 Listeners
26,332 Listeners
39 Listeners
110,865 Listeners
124 Listeners
318 Listeners
60 Listeners
88 Listeners
31 Listeners
146 Listeners
15,294 Listeners
11 Listeners
408 Listeners
48 Listeners
1,077 Listeners